Conflict of interest: The authors declare no financial or commercial conflict of interest. Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors. “
“Members of the TNF and TNF receptor (TNFR) superfamily play important roles in the maintenance Panobinostat in vitro of homeostasis of the immune system.

Furthermore, several members of the TNFR family participate in T-cell activation and sustaining T-cell responses. We have shown that TNFR2 regulates T-cell activation by lowering the activation threshold and providing costimulatory signaling. Furthermore, activated TNFR2−/− CD8+ T cells are highly resistant to activation-induced cell death (AICD). Here, we showed that using anti-TNFR2 antibodies to block TNFR2 on activated WT CD8+ T cells rendered them resistant to AICD. This resistance of activated TNFR2−/− CD8+ T cells to AICD correlated with the accumulation of TNF receptor-associated factor 2 (TRAF2). Overexpression

of TRAF2 by retroviral transfection and knockdown of TRAF2 by small interfering RNA also support this conclusion. Furthermore, neutralizing TNF-α reduced TRAF2 accumulation in activated TNFR2−/− CD8+ T cells and increased PLX4032 price their susceptibility to AICD. AICD-resistant TNFR2−/− CD8+ T cells expressed elevated levels of phosphorylated IκBα and higher DNA-binding activity of the p65 NK-κB subunit and neutralization of TNF-α blocked this increase. Therefore, in activated TNFR2−/− CD8+ T cells, TNFR1 functions as a survival receptor by utilizing high intracellular levels of TRAF2 to promote IκBα phosphorylation and NF-κB activation. More than 40 members of TNF and TNF receptor (TNFR) superfamily have been identified. The biological

functions of this superfamily encompass beneficial and protective effects in Thalidomide inflammation, autoimmunity and host defence as well as a critical role in organogenesis 1, 2. Furthermore, several members of the TNFR superfamily, particularly OX-40, 4-1BB, CD27, CD30 and HVEM (herpes virus entry mediator), have been shown to deliver both early and late signals to T cells after encounter with antigen 3–5. These signals are important for both the initiation of immune responses and the generation of long-lived immunity. We have shown that TNFR2 functions as a costimulatory molecule in T-cell activation and plays crucial roles in regulating the entry of activated cells into cell cycle and the survival of activated T cells 6–8. Interestingly, anti-CD3+IL-2-activated TNFR2−/− CD8+ T cells are highly resistant to activation-induced cell death (AICD) compared with WT cells 9, 10. However, the mechanism by which TNFR2 regulates AICD in activated CD8+ T cells has not been determined. The main goal of this study was to define the mechanism by which TNFR2 regulates AICD in activated T cells.